JPRN-UMIN000002570已完成2 期
Phase II study of weekly amrubicin in patients with refractory or relapsed non-small cell lung cancer - Phase II study of weekly amrubicin for non-small cell lung cancer patients
ational Hospital Organization Nagoya Medical Center0 个研究点目标入组 43 人开始时间: 2009年10月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 43
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Contraindication for amrubicin 2. Carcinomatous pleuritis, pericarditis, peritonitis and other metastasis with local therapy indication 3. Patient can not enroll during radiotherapy, but can be registered after interval (chest: four weeks; without chest: one weeks). 4. Serious medical complication: Uncontrolled angina pectoris, myocardial infarction for less than 3 months, patient with cardiac failure. Uncontrolled diabetes mellitus, hypertension. 5. Infected patients 6. Other clinical difficulties in this study
研究者
相似试验
已完成
不适用
Phase II Study of Amrubicin in Patients with Non-Small Cell Lung Cancer Previously Treated with Platinum-Based ChemotherapyAll patients had histologocally or cytologically confirmed locally advanced (non-irradiated) or metastatic NSCLC, with failure of platinum-based chemotherapy (exception for UFT and gefitinib).JPRN-C000000071West Japan Oncology Group60
未知
不适用
A phase II study of Amrubicin in patients with previously treated small cell lung cancersmall cell lung cancerJPRN-C000000141Kinki University School of Medicine30
已完成
2 期
Phase 2 Study of Amrubicin for patients with recurrent advanced squamous cell lung cancer after first line treatment.Recurrent squamous cell lung cancerJPRN-UMIN000006270Kansai Medical University Hirakata Hospital40
已完成
2 期
Phase II study of amrubicin for previously treated advanced non-small cell lung cancerRecurrent non-small cell lung cancerJPRN-UMIN000001751Gunma University Hospital35
已完成
不适用
Phase 2 study of amrubicin in previously treated patients with malignant pleural mesotheliomaMalignant pleural mesotheliomaJPRN-UMIN000006381agasaki University Hospital32